The program leads a featured paper in “Nature Reviews Clinical Oncology.”
The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) Brain Tumor Program led a major paper that has been highlighted as a featured article in Nature Reviews Clinical Oncology (NRCO).
Part of the highly selective Nature Reviews portfolio, NRCO has long been one of the top 20 journals in the world by impact factor (2024 JCR 81.1). The article "Leptomeningeal Metastatic Disease: New Frontiers and Future Directions" synthesizes historic and emerging evidence from multiple fields of biomedicine as well as biostatistics and trial design to provide a state-of-the-art discussion of this uniquely challenging disease entity, where median survival after diagnosis is typically between three to eight months.
Amongst a multidisciplinary expert group drawn from multiple countries, the first author (Ahmad Ozair, MD, MPH, postdoctoral fellow) and several other coauthors (Graeme Woodworth, MD, chair of neurosurgery; Lily Pham, MD, assistant professor of neurology) were affiliated with the UMGCCC Brain Tumor Program.
Link to the paper: https://www.nature.com/articles/s41571-024-00970-3